1998
DOI: 10.1038/28970
|View full text |Cite
|
Sign up to set email alerts
|

Triclosan targets lipid synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

12
720
2
19

Year Published

1999
1999
2013
2013

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 935 publications
(753 citation statements)
references
References 8 publications
(1 reference statement)
12
720
2
19
Order By: Relevance
“…[1,2-14 C]acetate (50 Ci/ml [60 mCi/mmol] sodium acetate; NEN) was added. After 2 h, the parasites were isolated, washed thoroughly with phosphate-buffered saline, lysed, sonicated, spotted onto a Whatman 3MM paper disk, and counted in scintillation fluid for estimation of the level of incorporation of [ 14 C]acetate into fatty acids (18). The pretreated cultures were also analyzed for inhibition of growth by microscopy and by monitoring the incorporation of [ 35 S]methionine (10 mCi/ml, 1,175 Ci/mmol; NEN) into the proteins.…”
Section: Methodsmentioning
confidence: 99%
“…[1,2-14 C]acetate (50 Ci/ml [60 mCi/mmol] sodium acetate; NEN) was added. After 2 h, the parasites were isolated, washed thoroughly with phosphate-buffered saline, lysed, sonicated, spotted onto a Whatman 3MM paper disk, and counted in scintillation fluid for estimation of the level of incorporation of [ 14 C]acetate into fatty acids (18). The pretreated cultures were also analyzed for inhibition of growth by microscopy and by monitoring the incorporation of [ 35 S]methionine (10 mCi/ml, 1,175 Ci/mmol; NEN) into the proteins.…”
Section: Methodsmentioning
confidence: 99%
“…36,37,75,76 Of the seven variants, only four had measurable activity, F93V, R96M, R96G, and F203L (Table 1). The F93V and F203L variants had significant reductions in activity (126−190-fold reduction in k cat ).…”
Section: Journal Of Medicinal Chemistrymentioning
confidence: 99%
“…Some inhibitors of other bacterial FAS are known. Triclosan and isoniazid, which are currently used antibacterial agents, have been demonstrated to act by inhibiting FabI [5,6]. Cephalochromin and unsaturated fatty acids acting as FabI inhibitors [7,8], atromentin acting as a FabK inhibitor [9], cerulenin and thiolactomycin acting as FabH/B inhibitors [3], and platensimycin and phomallenic acid acting as FabF inhibitors [10,11] were isolated from microorganisms.…”
mentioning
confidence: 99%